184 related articles for article (PubMed ID: 11859242)
1. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma.
Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH
Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.
Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C
Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 variants in osteosarcoma.
Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms.
Lee SC; Harn HJ; Lin TS; Yeh KT; Liu YC; Tsai CS; Cheng YL
Ann Thorac Surg; 2003 Jul; 76(1):213-8; discussion 218. PubMed ID: 12842543
[TBL] [Abstract][Full Text] [Related]
5. CD44: survival and metastasis in chondrosarcoma.
Heyse TJ; Malcherczyk D; Moll R; Timmesfeld N; Wapelhorst J; Fuchs-Winkelmann S; Paletta JR; Schofer MD
Osteoarthritis Cartilage; 2010 Jun; 18(6):849-56. PubMed ID: 20171296
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
[TBL] [Abstract][Full Text] [Related]
8. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance].
Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan.
Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP
J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096
[TBL] [Abstract][Full Text] [Related]
10. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival.
Endo K; Terada T
J Hepatol; 2000 Jan; 32(1):78-84. PubMed ID: 10673070
[TBL] [Abstract][Full Text] [Related]
11. CD44 splice variants as prognostic markers in colorectal cancer.
Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
Ashida K; Terada T; Kitamura Y; Kaibara N
Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
[TBL] [Abstract][Full Text] [Related]
13. CD44 loss in gastric stromal tumors as a prognostic marker.
Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma.
Deng Z; Niu G; Cai L; Wei R; Zhao X
Biomed Res Int; 2013; 2013():496193. PubMed ID: 23971040
[TBL] [Abstract][Full Text] [Related]
15. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases.
Tzankov A; Pehrs AC; Zimpfer A; Ascani S; Lugli A; Pileri S; Dirnhofer S
J Clin Pathol; 2003 Oct; 56(10):747-52. PubMed ID: 14514777
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of CD44s, MMP-9, and Ki-67: possible association with invasion, metastasis, and recurrence of osteosarcoma].
Peng TS; Qiu JS; Wu HX; Liang HZ; Luo CQ
Ai Zheng; 2002 Jul; 21(7):745-50. PubMed ID: 12479099
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
Tran TA; Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of CD44 isoform expression in endometrial cancer.
Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C
Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 isoforms and beta 1,6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential.
Seelentag WK; Böni R; Günthert U; Futo E; Burg G; Heitz PU; Roth J
J Cutan Pathol; 1997 Apr; 24(4):206-11. PubMed ID: 9138110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
